Lenalidomide for systemic lupus erythematosus with refractory cutaneous eruptions

Rheumatology (Oxford). 2023 Oct 3;62(10):e293-e294. doi: 10.1093/rheumatology/kead116.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Exanthema*
  • Humans
  • Lenalidomide
  • Lupus Erythematosus, Cutaneous* / drug therapy
  • Lupus Erythematosus, Systemic* / complications
  • Lupus Erythematosus, Systemic* / drug therapy
  • Thalidomide / therapeutic use

Substances

  • Lenalidomide
  • Thalidomide